β-Amyloid 31-35
98%
- Product Code: 64119
CAS:
149385-65-9
| Molecular Weight: | 545.74 g./mol | Molecular Formula: | C₂₅H₄₇N₅O₆S |
|---|---|---|---|
| EC Number: | MDL Number: | ||
| Melting Point: | Boiling Point: | ||
| Density: | Storage Condition: | 2-8℃ |
Product Description:
This peptide fragment is primarily utilized in research focused on understanding the mechanisms of Alzheimer's disease. It is often employed in studies investigating the aggregation and neurotoxic effects of amyloid peptides, which are key factors in the development of Alzheimer's. Researchers use it to explore how these peptides interact with neuronal cells, potentially leading to cell death and cognitive decline. Additionally, it serves as a model compound in the development of therapeutic agents aimed at inhibiting amyloid aggregation or mitigating its toxic effects. Its application extends to in vitro and in vivo experiments designed to elucidate the pathological pathways associated with amyloid plaques in the brain.
Sizes / Availability / Pricing:
| Size (g) | Availability | Price | Quantity |
|---|---|---|---|
| 0.001 | 10-20 days | $215.48 |
+
-
|
| 0.005 | 10-20 days | $430.96 |
+
-
|
β-Amyloid 31-35
This peptide fragment is primarily utilized in research focused on understanding the mechanisms of Alzheimer's disease. It is often employed in studies investigating the aggregation and neurotoxic effects of amyloid peptides, which are key factors in the development of Alzheimer's. Researchers use it to explore how these peptides interact with neuronal cells, potentially leading to cell death and cognitive decline. Additionally, it serves as a model compound in the development of therapeutic agents aimed at inhibiting amyloid aggregation or mitigating its toxic effects. Its application extends to in vitro and in vivo experiments designed to elucidate the pathological pathways associated with amyloid plaques in the brain.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Cart
No products
Subtotal:
$0.00
$0.00
Total :